The short interest data is out from the July 31 settlement date and, with a couple of notable exceptions, short sellers generally have retreated from their gambles on biotech firms. For the…
Jon OggThese are some of the top analyst upgrades, downgrades and initiations seen from Wall St. research calls this Thursday morning. Abercrombie & Fitch Co. (NYSE: ANF) cut to Neutral at Baird…
Jon OggThese are some of the top analyst upgrades, downgrades and initiations seen from Wall S. research calls this Monday morning. Biogen Idec Inc. (NASDAQ: BIIB) started as Outperform at Leerink Swann. Cinemark Holdings (NYSE:…
Teva Pharmaceutical Industries Limited (NYSE: TEVA) are up 4.7% a $39.75 on more than 12 million shares, while Momenta Pharmaceuticals Inc. (NASDAQ: MNTA) are down over 22% at $13.19 on more than…
Huntington Asset Advisors has announced the launch of an actively managed exchange-traded fund via Huntington Strategy Shares called the Huntington EcoLogical Strategy Shares ETF (HECO). This is the first of two ETFs the firm…
When corporate management and insiders unload shares of stock, investors often look at the transactions. This is legal insider trading that generally comes from planned share sales and/or via the exercising of…
While the media keeps putting the fear of Europe in you, stocks have bounced handily with the DJIA having bounced some 600 points in the last week and a half. Amazingly, some…
Jon OggThese are some of the top analyst upgrades, downgrades and initiations seen in Wall Street research calls this Tuesday. AECOM Technology Corporation (NYSE: ACM) Cut to Underperform at BofA/ML. Alnylam Pharmaceuticals,…
Jon OggThese are some of the top analyst upgrades, downgrades, and initiations seen from Wall Street research calls this Wednesday. American International Group (NYSE: AIG) Raised to Outperform at Bernstein. Bazaarvoice Inc.…
Biogen Idec Inc. (NASDAQ: BIIB) has agreed to acquire privately-held Stromedix Inc. for a total price that could reach $562.5 million. Stromedix is developing “innovative therapies for fibrosis and organ failure.” Under…
Paul Ausick Jon OggThese are some of the top analyst upgrades, downgrades, and initiations seen from Wall Street brokerage and research firms this Tuesday morning. Arch Coal Inc. (NYSE: ACI) Cut to Hold at…
The Pharmaceutical Research and Manufacturers of America (PhRMA) has spoken out against the new 2013 budget proposed by President Obama. PhRMA represents leading pharmaceutical research and biotechnology companies and some of the…
These are some of the top analyst upgrades, downgrades, and initiations seen from Wall Street brokerage and research firms this Friday morning. Altera Corporation (NASDAQ: ALTR) Cut to Underperform as Bear of the…
Credit Suisse is making a change in its Global Biotechnology outlook and says the is ‘room to run on generalist interest.’ Biogen Idec Inc. (NASDAQ: BIIB) is named as Credit Suisse’s preferred choice in…
Tuesday is going to be full of major earnings reports, two of which are DJIA components. These are not the only major earnings, but ten we will be watching closely are as…
